TokenPost·
Veracyte Shares Fall 56% After Updating 2026 Revenue Outlook
The stock fell $29.18 to $23.34 in the final half-hour of Thursday’s trading.
More news
- TokenPostKrispy Kreme Raises 2026 Net Revenue Forecast, Keeps Systemwide Sales Growth Outlook
- TokenPostLive Nation Raises Ticketing Outlook, Projects Nearly 180 Million Fans
- TokenPostLayerZero Falls 12.77% as 75 of 90 Cryptocurrencies Excluding Stablecoins Decline
- Crypto Briefing5-year Treasury yield for first time since 2007, impacting REITs
- TokenPostHinojosa Says Texas Must ‘Stop What We Are Doing With Data Centers’
- TokenPostBinance TSMUSDT Equity Perpetual Trades Below Four Averages